KoBioLabs Inc
348150
Company Profile
Business description
KoBioLabs Inc is a biotechnology company focused on Microbiome therapeutics. The main business of the company is the development of therapeutics and health functional foods based on human microbiome technology.
Contact
1 Gwanak-ro
Room 745-1, Building 220, Seoul National University Research Building
Silim-dong, Gwanak-gu
Seoul
KORT: +82 28889964
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 December 2026
Employees
57
Stocks News & Analysis
stocks
Pure-play data center share raises capital to fund AI demand
Funding the next wave of data center growth.
stocks
Chart of the Week: BHP’s growth story faces a reality check
China’s slowing economy could weigh on BHP’s future growth.
stocks
3 best ASX growth stocks to buy for the long term
Here’s three high-quality growth companies with wide moats.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,978.80 | 34.20 | -0.38% |
| CAC 40 | 8,338.08 | 39.78 | -0.47% |
| DAX 40 | 24,812.36 | 103.13 | -0.41% |
| Dow JONES (US) | 52,552.97 | 105.67 | -0.20% |
| FTSE 100 | 10,609.42 | 37.18 | 0.35% |
| HKSE | 24,505.38 | 503.22 | -2.01% |
| NASDAQ | 25,881.95 | 387.28 | -1.47% |
| Nikkei 225 | 64,141.12 | 2,694.42 | -4.03% |
| NZX 50 Index | 13,694.68 | 79.90 | 0.59% |
| S&P 500 | 7,533.77 | 38.63 | -0.51% |
| S&P/ASX 200 | 8,796.70 | 20.10 | -0.23% |
| SSE Composite Index | 3,764.15 | 118.26 | -3.05% |